Navigation Links
Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia
Date:6/3/2011

amp;language=English">acute myeloid leukemia (AML). Cornerstone's CPI-613 may represent a potential new alternative treatment for this disease

"I am very excited at the opportunity to present our data from the lab as well as our ongoing phase I trial at ASCO," said Timothy S. Pardee, M.D., Ph.D., lead investigator for the study. "CPI-613 is a very intriguing compound and I hope our studies will lead to improved care for patients who suffer hematologic malignancies."

Pardee will present the data at ASCO June 3-7 in Chicago. The poster session for the study will be on Monday, June 6 from 1 p.m. to 5 p.m. at McCormick Place Hall A. To view the complete abstract of the study (#6590), visit http://abstract.asco.org/AbstView_102_82032.html. More information about clinical trial enrollment is available at http://www.wakehealth.edu.

About CPI-613

CPI-613 is the first drug in a new chemical class that, through a novel mechanism, targets metabolic changes considered to be common to many, if not all, cancer types and not present in normal cells. Patients with solid tumors and hematologic cancers are currently being enrolled in multiple Phase I and Phase I/II human clinical trials evaluating CPI-613. These trials include a Phase I/II single agent trial for patients with solid tumors who have failed all other therapy options, a Phase I/II combination trial with gemcitabine in newly diagnosed or relapsed patients, and a single agent trial in hematologic malignancies. CPI-613 was granted orphan drug status by the US FDA for pancreatic cancer, which has a poor prognosis, spreads rapidly and often goes undetected in its early stages. For further information, visit http://www.cornerstonepharma.com.

About Cornerstone Pharmaceuticals

Cornerstone Pharmaceuticals, Inc. is a
'/>"/>

SOURCE Cornerstone Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
3. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
4. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
5. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
6. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
7. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
8. Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
9. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
10. Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
11. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... Nov. 28, 2014  (Booth #7309, North Hall) — ... its newest product, DCMSYS Interface WebBridge, at the 100th ... at McCormick Place, Chicago, Illinois . ... Designed for medical facilities of any size, ... to upload any non-standard data (e.g. JPEG, TFF, PDF, ...
(Date:11/28/2014)... 2014 Chinese magnesium alloy maker DongGuan Eontec ... magnesium alloy bone fixation screw has received Chinese regulatory ... and instrument and that the company acknowledges receipt of ... Science and Technology Daily journalists Wang Xiangming ... and founder, Professor Li Yangde , has been ...
(Date:11/27/2014)... -- Javon Bea Mercy Health System President and ... Janesville Craig High School and Janesville Parker High School ... and Janesville Police and ... Janesville School District. The event was ... schools and other organizations with the resources needed to ...
Breaking Medicine Technology:Dicom Systems Announces WebBridge Interface at RSNA 2014 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 3Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 4Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 2Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 3
... Medica,s ONCOLOGY and CancerNetwork today announced ... the clinical genetics service at Memorial Sloan-Kettering ... genetic testing in gastrointestinal cancers . ... colleagues bring clarity to when, why—and to what end—to refer ...
... Panasonic Healthcare Group today announced a new ... supplier for the hearing professional, which will allow ... at www.panasonic-hearingshop.com .  This is the first ... available for hearing care professionals to order online.    ...
Cached Medicine Technology:UBM Medica's ONCOLOGY to Feature Special Content on Role of Genetic Testing in GI Cancers 2Panasonic Reaches Distribution Agreement With The Hearing Shop 2Panasonic Reaches Distribution Agreement With The Hearing Shop 3Panasonic Reaches Distribution Agreement With The Hearing Shop 4
(Date:11/28/2014)... 2014 BambooFlooringChina.com has been recognized as ... Recently, the business has announced its new strand ... big discount on these new models. , Based on ... hands, without carpenter machines involved. It is crafted on ... great for do-it-yourselfers without hard work on installation, also ...
(Date:11/28/2014)... November 28, 2014 Dr. Diane Walder, ... , announced the addition of Dr. Bridgit Nolan to ... the practice after having completed her dermatology residency at ... Dr. Walder invited Dr. Nolan to join ... surgery and cosmetic dermatology. Not only does Dr. Nolan ...
(Date:11/28/2014)... 2014 Dr. Andrew Campbell, one of ... the expansion of Quintessa Aesthetic Center into a third ... at W307 N1497 Golf Road in Suite 200 and ... Campbell, the new Delafield location will offer a variety ... including: Botox, filler injectables , micro laser peels, ...
(Date:11/28/2014)... Melbourne, Australia (PRWEB) November 28, 2014 ... has undergone healthy growth over the past five ... population's increasing acceptance of therapies that are either ... conventional treatments. According to IBISWorld industry analyst David ... the ageing population and growing private health insurance ...
(Date:11/28/2014)... Nov. 27, 2014 (HealthDay News) -- Planning on seconds ... chronic heartburn -- clinically known as gastroesophageal reflux disease (GERD) ... Dr. Jordan Josephson, an ear, nose and throat specialist at ... tips to help manage GERD on Thanksgiving: ... at least two small meals throughout the day. It,s also ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com Introduces Its New Strand Woven Bamboo Flooring Collection 2Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2
... , , PITTSBURGH, Sept. 14 ... is prototyping an innovative stroke treatment device designed to speed up ... , Michele Migliuolo, NeuroInterventions President and ... presentation at the 3 Rivers Venture Fair in Pittsburgh on Sept. ...
... NY, Sept. 13 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova ... and develops novel drug targets that disrupt the advance ... Dr. Philip Gould as a Member Designate of its ... his career experience in multinational blue chip drug discovery ...
... ROCHESTER, Minn. -- Mayo Clinic researchers say that "teachable ... them diagnose cardiac infections without an invasive exam. Those ... on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco. ... sometimes chambers of the heart -- can be a ...
... say they,ll donate than do, leaving long waits for transplants ... and large say they support the idea of donating some ... lives, reality presents a different picture. , Just 38 percent ... organ and tissue donors, according to a report this year ...
... , , DENVER, Sept. 11 ... kidney care services for those diagnosed with chronic kidney disease (CKD), kicks ... events raising funds and awareness of CKD across the nation -- on ... (Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ) , , The ...
... ... PhD, JD, is Keynote Speaker on the Failed War on Drugs , ... Las Vegas, NV (PRWEB) September 11, 2009 -- ... Drug Policy Alliance advocating for drug reform in the United States as keynote speaker former ...
Cached Medicine News:Health News:Rapid-response Technology from NeuroInterventions, Inc. Aims to Quickly Restore Brain's Blood Flow After a Stroke 2Health News:GENova appoints Dr. Philip Gould to Scientific Advisory Board 2Health News:GENova appoints Dr. Philip Gould to Scientific Advisory Board 3Health News:Artificial intelligence helps diagnose cardiac infections 2Health News:For Organ Donation, Intent and Reality Don't Align 2Health News:For Organ Donation, Intent and Reality Don't Align 3Health News:DaVita Launches Nationwide Series of Kidney Awareness Run/Walks 2Health News:Healthcare Legal Issues Take the Stage at PAINWeek 2009 2Health News:Healthcare Legal Issues Take the Stage at PAINWeek 2009 3
Markham-Meyerding Hemilaminectomy Retractors, self-retaining, Right....
Bookwalter Spinal Retractor...
The TEW Cranial/Spinal Retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required....
... Infuse Bone Graft represents an rhBMP-2 (recombinant ... with a bovine-derived absorbable collagen sponge (ACS) ... fusion device is indicated for spinal fusion ... disc disease (DDD) at one level from ...
Medicine Products: